China Medical System Holdings Limited (SEHK: 867)
Health Care · Pharmaceuticals · HK
HK$10.54
+0.96% today · -23.9% 1Y
China Medical System Holdings Limited (SEHK: 867) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $3.27B.
Over the last twelve months the share price has lost 23.9%, trading between 9.51 and 15.52.
Tweenvest scores China Medical System Holdings Limited across four factors: quality 79/100, value 47/100, growth 21/100, dividend 35/100. Its strongest factor is quality.
867 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $3.27B
- Revenue (TTM)
- $1.28B
- P/E
- 14.41
- EPS
- 0.63
- Dividend yield
- 3.27%
- Beta (5Y)
- 1.09
- 52-week high
- HK$15.52
- 52-week low
- HK$9.51
- Avg volume (3M)
- —
- Shares outstanding
- 2.43B
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Santen Pharmaceutical Co., Ltd.TSE: 4536 | $3.42B | ¥1,684.00 | +2.34% |
| Wockhardt LimitedNSEI: WOCKPHARMA | $3.35B | Rs1,996.40 | -4.20% |
| Laboratorios Farmaceuticos Rovi, S.A.BME: ROVI | $3.32B | €58.75 | +1.21% |
| Jiangsu Nhwa Pharmaceutical Co., LTDSZSE: 002262 | $3.30B | CN¥21.74 | -4.36% |
| Guangdong Zhongsheng Pharmaceutical Co., Ltd.SZSE: 002317 | $3.23B | CN¥25.49 | +6.08% |
| Tarsus Pharmaceuticals, Inc.NasdaqGS: TARS | $3.21B | $75.77 | +3.57% |
| Tasly Pharmaceutical Group Co., LtdSHSE: 600535 | $3.17B | CN¥14.20 | +1.43% |
| Hybio Pharmaceutical Co., Ltd.SZSE: 300199 | $3.13B | CN¥23.71 | -0.88% |
Figures last refreshed Oct 11, 2026.